These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 7046368

  • 21. [The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
    Binz U, Wendt G.
    Fortschr Med; 1982 Dec 02; 100(45):2111-7. PubMed ID: 6757074
    [No Abstract] [Full Text] [Related]

  • 22. Early behavioural changes during antidepressant treatment in elderly patients.
    Kok RM, Vink D, Westers P, Nolen WA, Heeren TJ.
    Int J Geriatr Psychiatry; 2008 Jul 02; 23(7):769-71. PubMed ID: 18200609
    [No Abstract] [Full Text] [Related]

  • 23. [Repolarisation disturbances in the ECG under antidepressant drugs. A comparison of two drugs, differing in chemical structure and pharmacological profile (author's transl)].
    Schanda H, Saletu B.
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jul 02; 12(4):338-45. PubMed ID: 493336
    [Abstract] [Full Text] [Related]

  • 24. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD, Dreyfus JF, Pichot P.
    Br J Clin Pharmacol; 1983 Jul 02; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [Abstract] [Full Text] [Related]

  • 25. Generalizability of antidepressant efficacy trials.
    Zimmerman M, Posternak MA, Chelminski I.
    Essent Psychopharmacol; 2004 Jul 02; 6(1):45-58. PubMed ID: 15612653
    [No Abstract] [Full Text] [Related]

  • 26. Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.
    Montgomery SA, Montgomery DB, McAuley R, Rani SJ, Roy D.
    Adv Biochem Psychopharmacol; 1982 Jul 02; 32():35-42. PubMed ID: 6211942
    [No Abstract] [Full Text] [Related]

  • 27. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA, Reimitz PE, Sennef C.
    Psychopharmacol Bull; 1997 Jul 02; 33(1):41-51. PubMed ID: 9133750
    [Abstract] [Full Text] [Related]

  • 28. A double-blind study of bupropion and placebo in depression.
    Feighner JP, Meredith CH, Stern WC, Hendrickson G, Miller LL.
    Am J Psychiatry; 1984 Apr 02; 141(4):525-9. PubMed ID: 6422779
    [Abstract] [Full Text] [Related]

  • 29. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
    Spielmans GI, McFall JP.
    J Nerv Ment Dis; 2006 Nov 02; 194(11):845-52. PubMed ID: 17102709
    [Abstract] [Full Text] [Related]

  • 30. [Clinical evaluation of the antidepressive action of sulfoadenosyl-L-methionine compared with that of chlorimipramine].
    Giner Ubago J, González Infante JM, Blanco Picabia A.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984 Nov 02; 12(1):73-80. PubMed ID: 6372376
    [No Abstract] [Full Text] [Related]

  • 31. Pituitary-adrenocortical hyperfunction and intolerance to fluvoxamine, a selective serotonin uptake inhibitor.
    Brown WA, Arato M, Shrivastava R.
    Am J Psychiatry; 1986 Jan 02; 143(1):88-90. PubMed ID: 3079969
    [Abstract] [Full Text] [Related]

  • 32. Effects of two antidepressants on memory performance in depressed outpatients: a double-blind study.
    Lamping DL, Spring B, Gelenberg AJ.
    Psychopharmacology (Berl); 1984 Jan 02; 84(2):254-61. PubMed ID: 6438686
    [Abstract] [Full Text] [Related]

  • 33. First results of an open phase II study with the antidepressant paroxetine.
    Stuppäck C, Schubert H, Barnas C, Mair M, Schifferle I, Unterweger B, Wömhart L, Fleischhacker WW, Hinterhuber H.
    Pharmacopsychiatry; 1988 Nov 02; 21(6):369-70. PubMed ID: 2977442
    [No Abstract] [Full Text] [Related]

  • 34. Four new atypical antidepressants (trazodone, mianserin, nomifensine, caroxazone): results of controlled trials.
    Cassano GB, Conti L, Dell'Osso L, Massimetti G.
    Adv Biochem Psychopharmacol; 1982 Nov 02; 32():125-39. PubMed ID: 7046361
    [No Abstract] [Full Text] [Related]

  • 35. Is loss of antidepressant effect during continuation therapy related to placebo effect?
    Harrison W, Stewart JW, McGrath PJ, Tricamo E, Quitkin FM.
    Psychopharmacol Bull; 1988 Nov 02; 24(1):9-13. PubMed ID: 3290953
    [No Abstract] [Full Text] [Related]

  • 36. Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients.
    Mück-Seler D, Jakovljević M, Deanović Z.
    J Affect Disord; 1991 Nov 02; 23(3):157-64. PubMed ID: 1774431
    [Abstract] [Full Text] [Related]

  • 37. Comments on "Clinical trials of antidepressants: time to shift to a new model" by Dr Katz.
    Rickels K, Robinson DS.
    J Clin Psychopharmacol; 2009 Apr 02; 29(2):197-8; author reply 198-9. PubMed ID: 19512995
    [No Abstract] [Full Text] [Related]

  • 38. Viloxiazine--a new antidepressant.
    Wheatley D.
    Curr Ther Res Clin Exp; 1974 Aug 02; 16(8):821-8. PubMed ID: 4217250
    [No Abstract] [Full Text] [Related]

  • 39. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT, Isaac MB, Gallo F, Tournoux A.
    Hum Psychopharmacol; 2003 Dec 02; 18(8):595-601. PubMed ID: 14696018
    [Abstract] [Full Text] [Related]

  • 40. Open-label non-randomized versus double-blind randomized antidepressive treatment: what are the advantages of clinical decision over randomization?
    Deuschle M, Krumm B, Bindeballe N, Colla M, Hamann B, Lederbogen F, Gilles M, Heuser I.
    Pharmacopsychiatry; 2004 Nov 02; 37(6):299-302. PubMed ID: 15551197
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.